Greek cancer patients still waiting for access to essential biomarker testing
Eight months after Greece introduced reforms to expand reimbursement for cancer biomarker testing, thousands of patients are still waiting for access as negotiations continue and key eligibility…
Read the full articleYou might also wanna read
Comprehensive Genomic Profiling Delays in Lung Cancer: Biopsy-to-Order Time Remains the Biggest Barrier
Comprehensive genomic profiling has changed lung cancer care. But a new analysis in JCO Oncology Practice shows that many patients still wai
Cancer waiting times: Latest updates and analysis
Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer The post C
Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer
How confident are you navigating biomarker conversations with your gastric cancer patients?
mdsc.pe·27d agoCancer groups warn of unequal access after Kela subsidy change
Finnish cancer patient organisations have raised concerns over unequal access to treatment after the Social Insurance Institution (Kela) sto
ABPI statement on biomarker testing
The ABPI commented in support of a call led by the Institute of Cancer Research (ICR) for all cancer patients to be offered genetic testing
Timing of ctDNA Testing in HR+/HER2- Advanced Breast Cancer
Conditions : Advanced Breast Cancer Sponsors : Geneplus-Beijing Co. Ltd. Recruiting
Comments
Sign in to join the conversation.
No comments yet. Be the first.